Trials / Completed
CompletedNCT00801788
Single Dose Pharmacokinetics of Egalet® Oxycodone
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Egalet Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® oxycodone formulations and compare to a marketed oxycodone product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone hydrochloride | Extended release tablet |
| DRUG | Oxycodone hydrochloride | Extended release tablet |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2008-10-01
- Completion
- 2009-02-01
- First posted
- 2008-12-04
- Last updated
- 2016-08-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00801788. Inclusion in this directory is not an endorsement.